yellow fever immune globulin
Biologicalexperimental
Clinical trial activity
1 trials · 3 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started Jun 1, 2006 (NCT00254826)
Timeline
2000s
- Jan 1, 2006
Earliest Phase 1 Sponsor(trial)
Indications
Studied for
Mechanism of action
- Yellow fever virusImmunity, passive
immunity, passive - yellow fever virus
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- yellow fever immune globulin
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT00254826 | Phase 1 | Jun 1, 2006 | Centers for Disease Control and Prevention (CDC), Emory University, Sanofi-Aventis |
Showing 1 of 1 trials
Page 1 / 1
Organizations
Research & Development (3)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Centers for Disease Control and Prevention (CDC) | Government | 1 | 0 | 1 | 2006 |
| Emory University | Academic/Hospital | 1 | 1 | 1 | 2006 |
| Sanofi-Aventis | For profit | 1 | 0 | 1 | 2006 |
3 organizations
Page 1 / 1